The Latest Cardiac and Vascular News
LOS ANGELES, CA, April 26, 2019 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB: ENDV) (“Endonovo” or the “Company”), a commercial-stage developer of non-invasive Electroceutical™ therapeutic devices, today announced a corporate update and business plan for the remainder of 2019. Revenue projections for the first quarter ended March 31, 2019 are expected to […]
LOS ANGELES, CA , March 29, 2019 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB: ENDV) (“Endonovo” or the “Company”), today announced an agreement with a nationally recognized hospital group to enhance the quality of the healthcare/patient experience through the use of its electroceutical therapeutic device, SofPulse®. Endonovo has been approved to […]
LOS ANGELES, CA, March 20, 2019 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB: ENDV) (“Endonovo” or the “Company”), Alan Collier, Endonovo’s Chief Executive Officer, stated “We are pleased to announce our partnership with SunMED Medical Solutions (“SunMED”). SunMED is one of the premier medical equipment distributors and claims experts in the country. […]
LOS ANGELES, CA, Feb. 12, 2018 (GLOBE NEWSWIRE) — Endonovo Therapeutics (OTCQB: ENDV) (“Endonovo” or the “Company”), a commercial-stage developer of non-invasive wearable Electroceutical™ devices, today announced positive results from a study of critical limb ischemia (CLI) in mice. Animals treated three times per day with the Company’s Pulsed Electromagnetic Fields (PEMF) […]
